News / Events

EVERSANA Proudly Sponsors The 5th Annual CAR-TCR Summit

EVERSANA is a proud sponsor and panelist of the 5th annual CAR-TCR Summit this September 11-13 in Boston, Massachusetts. The summit brings together more than 1000 global leaders dedicated to innovating, developing and delivering CAR and TCR cell-based immunotherapies to patients across pharma, biotech, regulatory bodies, academia, and solution/service providers. EVERSANA’s General Manager Seth Gordon […]

Visit EVERSANA at the National Association of Specialty Pharmacy (NASP)

Meet our team of experts at the NASP Annual Meeting & Expo in Washington, D.C. September 9 – 12, 2019. EVERSANA BOOTH #914 Tuesday, September 10 7:00 am – 8:00 pm Wednesday, September 11 6:00 am – 2:30 pm Disruptive Therapies Call for a Disruptive Business Model Scientific breakthroughs in regenerative therapies are disrupting the […]

EVERSANA Sponsors EPP’s 9th Life Sciences Pricing Forum

Meet us at EPP’s 9th Life Sciences Pricing Forum in Munich, Germany on October 14-16. Schedule a meeting with the EVERSANA Global Pricing Team EVERSANA is particularly pleased to be partnering with the EPP this year as we tackle critical topics for Global Pricing such as: Pricing in a complex eco-system Pricing for new therapies […]

EVERSANA Sponsors Medicaid Drug Rebate Program Summit

Join us at the 2019 Medicaid Drug Rebate Program Summit, September 23-25 in Chicago, Illinois! The summit provides unparalleled access to the government regulators creating the rules, the industry leaders interpreting them, and the pharmaceutical executives implementing them. This year, join us for these sessions: PRESENTATION: Where Can a GP Person Add More Value With […]

EVERSANA Sponsors World Drug Safety Congress Europe 2019

Terrapinn’s World Drug Safety Congress Europe, September 10-11 in Amsterdam, focuses on how to drive pharmacovigilance operations forward, better drug safety capabilities, technological functions and risk management measures. We help you make the best drug safety decisions, so that you can protect your brand and improve your patient’s outcomes. Here are some of our solutions […]

EVERSANA Sponsors HUB and SPP Model Optimization

CBI’s 13th HUB and SPP Model Optimization, September 26 and 27 in San Diego, California, is designed to provide the strategies needed to develop and integrate hub programs and other patient-centric services to ensure product access and maximize reimbursement. This year, conference organizers included a 90-minute patient experience panel; an exclusive, manufacturer-only round up; and 2 […]

EVERSANA™ opens offices in Singapore & Mumbai as Asia Pacific commercial business rapidly expands

CHICAGO – August 6, 2019 – EVERSANA™, the leading independent provider of global commercial services to the life science industry, today announced the rapid expansion of its Asia Pacific business with the addition of two new offices in Singapore and Mumbai. The announcement comes as the company appoints a regional leadership team which will be […]

See EVERSANA at NACDS Total Store Expo 2019

We will be at NACDS Total Store Expo August 24-26 2019, in Boston, Massachusetts. Stop by our booth so we can show you how we are disrupting the industry with integrated commercial services to address any access, affordability and distribution needs. Our services ranging from field solutions and co-pay programs to complex 3PL management and […]

EVERSANA Presents at IM4US

EVERSANA’s Mike Kalfus will co-present at the 2019 IM4US (Integrative Medicine for the Underserved) conference: Solidarity and Self Care – Supporting Social Justice and Balance in Integrative Care, held August 22-24. Presentation: “Advancing Patient Outcomes for Economically Vulnerable Patients: Approaches and Learning from a Large Health Systems Program” Date: Saturday, August 24 from 3:00-4:00pm Location: […]

Cryoport and EVERSANA Form Strategic Alliance to Accelerate Regenerative Medicine Supply Chain

IRVINE, California, July 11, 2019 – Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) and EVERSANA™ have announced a strategic alliance to further create a fully integrated regenerative medicine supply chain solution. The alliance will be designed to leverage EVERSANA’s position as the leading provider of commercial services addressing access, affordability and adherence challenges for cell and […]